Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
BioTissue Logo
BioTissue Growth Score
82
CB Rank
14272
Heat Score
67
BioTissue offers regenerative amniotic tissue-based products for ophthalmology, optometry, musculoskeletal, and wound care markets.
Founded
obfuscation
PrivateSeries C Miami, Florida, United States251-500 biotissue.com/
Biotechnology
Health Care
Medical
Medical Device
Pharmaceutical
Therapeutics
Overview

BioTissue
Total Funding
obfuscation
Growth Score
82
Heat Score
67

Total Funding
obfuscation
obfuscation
Series C raised
obfuscation
Growth Score82
-10 pts
in past quarter
Heat Score 67
-5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About BioTissue

CB Rank
14272
BioTissue offers regenerative amniotic tissue-based products for ophthalmology, optometry, musculoskeletal, and wound care markets.
Founded
obfuscation
PrivateSeries C Miami, Florida, United States251-500 biotissue.com/
Biotechnology
Health Care
Medical
Medical Device
Pharmaceutical
Therapeutics

Funding Rounds

Series C
OBF
in
obfuscation
Series B
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name BioTissue , Inc.
Also Known As Tissuetech
Operating Status Active
Company Type For Profit
Founders  Amy H. Tseng, Scheffer C.G. Tseng
About the Company

BioTissue is an innovative technology company that uses products derived from human amniotic and umbilical cord tissues. Its medical technology platform markets innovative amniotic and umbilical cord-based products, thereby enabling physicians to avail of enhanced regenerative healing technology in eye care, wound care, and orthopedics.

Tissuetech

was founded in 2001 and is headquartered in Miami, Florida.

Phone Number +1 786-817-6690
Contact Email info@tissuetech.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Insight

See this Growth Insight
BioTissue is
Lorem
 to be growing
Top Contributing Factors
Operations Contraction

Growth Prediction

See this Growth Prediction

Products & Services

Clarix 1K
A cryopreserved ultra-thick human birth tissue allograft used as an adjunct in urological surgeries to support healing by managing inflammation and adhesion formation.
Prokera
A biologic corneal bandage device using cryopreserved amniotic membrane to treat ocular surface diseases by reducing inflammation and promoting healing.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series C - BioTissue Logo
Series C - BioTissue
2
obfuscation
Essex Woodlands Healthcare PartnersSeries C
obfuscation
Series C - BioTissue Logo
Series C - BioTissue
2
obfuscation
Essex Woodlands Healthcare PartnersSeries C
obfuscation
Series C - BioTissue Logo
Series C - BioTissue
2
obfuscation
Essex Woodlands Healthcare PartnersSeries C
obfuscation
Series C - BioTissue Logo
Series C - BioTissue
2
obfuscation
Essex Woodlands Healthcare PartnersSeries C
obfuscation
Series C - BioTissue Logo
Series C - BioTissue
2
obfuscation
Essex Woodlands Healthcare PartnersSeries C

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series C - BioTissue Logo
Series C - BioTissue
2
obfuscation
Essex Woodlands Healthcare PartnersSeries C
obfuscation
Series C - BioTissue Logo
Series C - BioTissue
2
obfuscation
Essex Woodlands Healthcare PartnersSeries C
obfuscation
Series C - BioTissue Logo
Series C - BioTissue
2
obfuscation
Essex Woodlands Healthcare PartnersSeries C
obfuscation
Series C - BioTissue Logo
Series C - BioTissue
2
obfuscation
Essex Woodlands Healthcare PartnersSeries C
obfuscation
Series C - BioTissue Logo
Series C - BioTissue
2
obfuscation
Essex Woodlands Healthcare PartnersSeries C

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 251-500 Employee Profiles 7 Board Members and Advisors 2 Contacts 257

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 25, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 19, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 21, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

2,896
3.21%
 in past month

IT Spend

$3MThis year, BioTissue is projected to spend $3M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Zoom Logo
Zoom
100
Google Nexus Logo
Google Nexus
100
Printing United Logo
Printing United
99

Actively Used Products

29BioTissue uses 29 technology products and services including HTML5, F5 NGINX, and  MailChannels Cloud, according to G2 Stack.

Active Website Tech Count

51BioTissue is actively using 51 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, SSL by Default, and  Viewport Meta.

Total IP

63The intellectual property of BioTissue includes 48 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, BioTissue has registered 15 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations

Sub-Organizations

Number of Sub-Orgs 1
Which industries do these Sub-Organization operate in?
Surgical and Wound Care business Logo
Surgical and Wound Care businessDivision
Frequently Asked Questions

Where is BioTissue's headquarters? BioTissue is located in Miami, Florida, United States.Who invested in BioTissue? BioTissue has 3 investors including Essex Woodlands Healthcare Partners and  Ballast Point Ventures.When was the last funding round for BioTissue? BioTissue closed its last funding round on
obfuscation
from a Series C round.Who are BioTissue's competitors? Alternatives and possible competitors to BioTissue may include Celularity, Healogics, and  Reprise Biomedical.How much funding has BioTissue raised to date? BioTissue has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3237dbc 1)
|